Oxygenta Pharmaceutical Share Price

Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals. Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 202122.The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs. The Company is doing contract manufacturing work for APL and also having its own production. The Company is engaged in manufacture of bulk drugs. It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and antiinflammatory drugs. The Company has plant located at Medak in Andhra Pradesh. The Company has been doing contract manufacturing work with APL for manufacturing of Cirprofloxacin HCL from QAcid and has been manufacturing Pantaprozole Sodium and Gabapentine for own production. To minimize the working capital requirement and to have consistent income, it is necessary to continue contract manufacturing work till the Company gets working capital limits from any Bank. This contract manufacturing helps it to meet major operational expenses of the Company. Since the Company started commercial production in July, 2015 after fire accident, it is in the process of stabilizing the manufacturing and marketing.

As of 3 Jan 2026, Oxygenta Pharmaceutical share price is ₹53.6. The stock opened at ₹53 and had closed at ₹53.6 the previous day. During today’s trading session, Oxygenta Pharmaceutical share price moved between ₹53.00 and ₹55.50, with an average price for the day of ₹54.25. Over the last 52 weeks, the stock has recorded a low of ₹52.10 and a high of ₹133.50. In terms of performance, Oxygenta Pharmaceutical share price has declined by 54.2% over the past six months and has declined by 38.64% over the last year.